董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Julia Gouw | 女 | Independent Director | 65 | 3.00万美元 | 0.28 | 2025-11-03 |
| Kang HuaiWang | 男 | President, Chief Executive Officer and Director | 68 | 25.00万美元 | 72.17 | 2025-11-03 |
| Chen Lung Tsai | 男 | Chairman | 73 | 4.42万美元 | 11.84 | 2025-11-03 |
| Joanne Imperial | 女 | Independent Director | 75 | 3.03万美元 | 0.28 | 2025-11-03 |
| Wen Herng Henry King | 男 | Independent Director | 61 | 2.75万美元 | 2.36 | 2025-11-03 |
| Hui Ying Kuo | 女 | Director | 54 | 2.75万美元 | 1.32 | 2025-11-03 |
| Michele Harari | 女 | Independent Director | 52 | 2.75万美元 | 5.90 | 2025-11-03 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Kang HuaiWang | 男 | President, Chief Executive Officer and Director | 68 | 25.00万美元 | 72.17 | 2025-11-03 |
| Douglas Atkinson | 男 | Head of Global Sales | 57 | 41.75万美元 | 10.99 | 2025-11-03 |
| Keri Jorgenson | -- | Director of Clinical Operations | -- | 未披露 | 未持股 | 2025-11-03 |
| David Garcia | 男 | Principal Financial Officer and Principal Accounting Officer | 51 | 62.53万美元 | 未持股 | 2025-11-03 |
董事简历
中英对照 | 中文 | 英文- Julia Gouw
-
Julia Gouw自2020年11月以来一直担任我们的董事会成员。Gouw女士是East West Bancorp, Inc.和East West Bank的前总裁，首席运营官和前董事，纳斯达克:EWBC是美国前30大银行之一，是中美之间的金融桥梁。在1989年加入East West Bank之前，Gouw女士是KPMG LLP国际会计师事务所的高级审计经理。Gouw女士加入East West Bank担任财务总监，并晋升为执行副总裁兼首席财务官（1994年至2008年）。Gouw女士从2009年到2016年3月退休担任总裁兼首席运营官。在高女士的领导下，East West实现了连续11年的创纪录盈利。Gouw女士曾五次被《美国银行家》杂志评为银行业最有影响力的25位女性之一，并两次获得《洛杉矶商业杂志》的“女性有所作为”奖，以表彰她的成就和贡献。Gouw女士还是托管组织的成员，该组织是国际妇女论坛的附属组织，该组织将在各个专业领域担任领导职务的杰出女性联系在一起。自2011年以来，Gouw女士一直担任Pacific Life（美国最大的人寿保险公司之一）的董事会成员，并担任投资和金融委员会主席。Gouw女士是纽约州持牌商业银行Piermont Bank的联席Founder，该银行成立于2019年，自成立以来，她一直担任董事会主席和审计委员会主席。自2017年以来，Gouw女士一直担任安大略省国际机场管理局专员。OIAA为南加州安大略国际机场的管理，运营，开发和营销提供了全面的指导。Gouw女士自2021年2月起担任VIZIO Holding Corp.（纽约证券交易所代码:VZIO）的董事会成员和审计委员会主席，该公司是一家专注于娱乐设备和智能电视平台的美国公司。Gouw女士拥有伊利诺伊大学香槟分校的会计学士学位。
Julia Gouw,has served as a board member and Chair of the Investment and Finance Committee for Pacific Life, an insurance company, since 2011; and as Chair of the Board for Piermont Bank, since 2019. Ms. Gouw also served as a board member and Chair of the Audit Committee for Vizio, a publicly traded technology company, from 2021 to 2024; as the President and Chief Operating Officer of East West Bank, from 2008 to 2016, Chief Financial Officer from 1994 to 2008, and Controller from 1989 to 1994; and as Senior Audit Manager at KPMG from 1983 to 1989. Ms. Gouw holds a B.S. in Accounting from the University of Illinois at Urbana-Champaign. - Julia Gouw自2020年11月以来一直担任我们的董事会成员。Gouw女士是East West Bancorp, Inc.和East West Bank的前总裁，首席运营官和前董事，纳斯达克:EWBC是美国前30大银行之一，是中美之间的金融桥梁。在1989年加入East West Bank之前，Gouw女士是KPMG LLP国际会计师事务所的高级审计经理。Gouw女士加入East West Bank担任财务总监，并晋升为执行副总裁兼首席财务官（1994年至2008年）。Gouw女士从2009年到2016年3月退休担任总裁兼首席运营官。在高女士的领导下，East West实现了连续11年的创纪录盈利。Gouw女士曾五次被《美国银行家》杂志评为银行业最有影响力的25位女性之一，并两次获得《洛杉矶商业杂志》的“女性有所作为”奖，以表彰她的成就和贡献。Gouw女士还是托管组织的成员，该组织是国际妇女论坛的附属组织，该组织将在各个专业领域担任领导职务的杰出女性联系在一起。自2011年以来，Gouw女士一直担任Pacific Life（美国最大的人寿保险公司之一）的董事会成员，并担任投资和金融委员会主席。Gouw女士是纽约州持牌商业银行Piermont Bank的联席Founder，该银行成立于2019年，自成立以来，她一直担任董事会主席和审计委员会主席。自2017年以来，Gouw女士一直担任安大略省国际机场管理局专员。OIAA为南加州安大略国际机场的管理，运营，开发和营销提供了全面的指导。Gouw女士自2021年2月起担任VIZIO Holding Corp.（纽约证券交易所代码:VZIO）的董事会成员和审计委员会主席，该公司是一家专注于娱乐设备和智能电视平台的美国公司。Gouw女士拥有伊利诺伊大学香槟分校的会计学士学位。
- Julia Gouw,has served as a board member and Chair of the Investment and Finance Committee for Pacific Life, an insurance company, since 2011; and as Chair of the Board for Piermont Bank, since 2019. Ms. Gouw also served as a board member and Chair of the Audit Committee for Vizio, a publicly traded technology company, from 2021 to 2024; as the President and Chief Operating Officer of East West Bank, from 2008 to 2016, Chief Financial Officer from 1994 to 2008, and Controller from 1989 to 1994; and as Senior Audit Manager at KPMG from 1983 to 1989. Ms. Gouw holds a B.S. in Accounting from the University of Illinois at Urbana-Champaign.
- Kang HuaiWang
-
康怀旺是Capsovision，Inc.的联合创始人和Capsovision，Inc.董事会成员，自2024年11月起担任Capsovision，Inc.总裁兼首席执行官，在此之前于2006年10月至2024年10月担任Capsovision，Inc.总裁兼首席技术官。在加入公司之前，王先生于2003年9月至2004年11月担任技术公司ESS技术的工程副总裁；于1996年3月至2003年8月担任视频处理芯片设计公司Divio，Inc的首席执行官和联合创始人；以及于1992年3月至1995年8月担任IC设计公司C-Cube Mircrosystem的设计经理。在1992年之前，王先生在半导体行业担任过各种工程职务。王先生拥有台湾国立交通大学电机工程学学士学位，以及得克萨斯农工大学电机工程学硕士学位。
Kang HuaiWang,is a co-founder of CapsoVision, Inc. and a member of CapsoVision, Inc. board of directors, and has served as CapsoVision, Inc. President and Chief Executive Officer since November 2024, and before then CapsoVision, Inc. President and Chief Technology Officer from October 2006 to October 2024. Prior to joining the Company, Mr. Wang was Vice President of Engineering for ESS Technology, a technology company from September 2003 to November 2004; Chief Executive Officer and co-founder of Divio, Inc, a video processing chip design company, from March 1996 to August 2003; and as Design Manager for C-Cube Mircrosystem, an IC design house from March 1992 to August 1995. Prior to 1992, Mr. Wang held various engineering roles in the semiconductor industry. Mr. Wang holds a B.S. in electrical engineering from National Chiao-Tung University in Taiwan, and a M.S. in electrical engineering from Texas A&M University. - 康怀旺是Capsovision，Inc.的联合创始人和Capsovision，Inc.董事会成员，自2024年11月起担任Capsovision，Inc.总裁兼首席执行官，在此之前于2006年10月至2024年10月担任Capsovision，Inc.总裁兼首席技术官。在加入公司之前，王先生于2003年9月至2004年11月担任技术公司ESS技术的工程副总裁；于1996年3月至2003年8月担任视频处理芯片设计公司Divio，Inc的首席执行官和联合创始人；以及于1992年3月至1995年8月担任IC设计公司C-Cube Mircrosystem的设计经理。在1992年之前，王先生在半导体行业担任过各种工程职务。王先生拥有台湾国立交通大学电机工程学学士学位，以及得克萨斯农工大学电机工程学硕士学位。
- Kang HuaiWang,is a co-founder of CapsoVision, Inc. and a member of CapsoVision, Inc. board of directors, and has served as CapsoVision, Inc. President and Chief Executive Officer since November 2024, and before then CapsoVision, Inc. President and Chief Technology Officer from October 2006 to October 2024. Prior to joining the Company, Mr. Wang was Vice President of Engineering for ESS Technology, a technology company from September 2003 to November 2004; Chief Executive Officer and co-founder of Divio, Inc, a video processing chip design company, from March 1996 to August 2003; and as Design Manager for C-Cube Mircrosystem, an IC design house from March 1992 to August 1995. Prior to 1992, Mr. Wang held various engineering roles in the semiconductor industry. Mr. Wang holds a B.S. in electrical engineering from National Chiao-Tung University in Taiwan, and a M.S. in electrical engineering from Texas A&M University.
- Chen Lung Tsai
-
Chen Lung Tsai，自2014年起担任Capsovision，Inc.董事会成员。蔡先生还曾于2018年至2023年担任技术创新公司One Test Systems的董事会主席；2016年至2018年担任核电站TeraPower的美国代表；2015年至2016年担任创新技术制造商Lucis-Tech的首席运营官和董事会董事；2010年至2015年担任固态存储公司Greenliant Systems的运营总裁和制造运营高级副总裁（“SVP”）；担任全球后端运营高级副总裁和Silicon Storage Technology董事会董事，1996-2010年的数据存储技术公司，以及半导体制造行业的其他各种工程角色。蔡先生拥有昭告大学的学士学位，以及佛罗里达理工学院的物理和电气工程硕士学位。
Chen Lung Tsai,has served as a member of CapsoVision, Inc. board of directors since 2014. Mr. Tsai also served as the Chairman of the Board for One Test Systems, a technology innovation company, from 2018 to 2023; as USA Representative for TeraPower, a nuclear power plant, from 2016 to 2018; as Chief Operations Officer and board director for Lucis-Tech, an innovative technology manufacturer, from 2015 to 2016; as President of Operations and Senior Vice President ("SVP") of Manufacturing Operations for Greenliant Systems, a solid state storage company, from 2010 to 2015; as SVP of Worldwide Backend Operations and a board director for Silicon Storage Technology, a data storage technology company from 1996 to 2010, as well as various other engineering roles in the semiconductor manufacturing industry. Mr. Tsai holds a B.S. from Show Chu University, and a M.S. in Physics and Electrical Engineering from the Florida Institute of Technology. - Chen Lung Tsai，自2014年起担任Capsovision，Inc.董事会成员。蔡先生还曾于2018年至2023年担任技术创新公司One Test Systems的董事会主席；2016年至2018年担任核电站TeraPower的美国代表；2015年至2016年担任创新技术制造商Lucis-Tech的首席运营官和董事会董事；2010年至2015年担任固态存储公司Greenliant Systems的运营总裁和制造运营高级副总裁（“SVP”）；担任全球后端运营高级副总裁和Silicon Storage Technology董事会董事，1996-2010年的数据存储技术公司，以及半导体制造行业的其他各种工程角色。蔡先生拥有昭告大学的学士学位，以及佛罗里达理工学院的物理和电气工程硕士学位。
- Chen Lung Tsai,has served as a member of CapsoVision, Inc. board of directors since 2014. Mr. Tsai also served as the Chairman of the Board for One Test Systems, a technology innovation company, from 2018 to 2023; as USA Representative for TeraPower, a nuclear power plant, from 2016 to 2018; as Chief Operations Officer and board director for Lucis-Tech, an innovative technology manufacturer, from 2015 to 2016; as President of Operations and Senior Vice President ("SVP") of Manufacturing Operations for Greenliant Systems, a solid state storage company, from 2010 to 2015; as SVP of Worldwide Backend Operations and a board director for Silicon Storage Technology, a data storage technology company from 1996 to 2010, as well as various other engineering roles in the semiconductor manufacturing industry. Mr. Tsai holds a B.S. from Show Chu University, and a M.S. in Physics and Electrical Engineering from the Florida Institute of Technology.
- Joanne Imperial
-
Joanne Imperial，自2025年起担任Capsovision，Inc.董事会成员。Imperial博士自2025年3月起担任医学研究公司HepQuant LLC的首席医疗官，并自2024年11月起担任临床事务总监。Imperial博士还曾于2020年9月至2024年10月担任医疗诊断公司Fortea的高级医疗总监；于2019年2月至2020年9月担任生物技术公司Blade Therapeutics的副总裁；于2017年2月至2019年2月担任制药公司Conatus Pharmaceuticals的高级医疗总监；于2014年8月至2017年2月担任生物技术公司Fibrogen的医疗总监；并于2010年8月至2014年8月担任制药公司Onyx Pharmaceuticals的医疗事务的医疗总监。Imperial博士还曾于1995年4月至2017年2月在斯坦福大学担任各种学术和教授职务；并于2007年8月至2010年2月担任加州大学旧金山分校临床副教授。Imperial博士拥有Thomas Moore大学的心理学学士学位和纽约医学院的医学博士学位。Imperial博士在新英格兰女执事医院完成了医学实习和临床营养/消化内科研究金，还获得了加州大学旧金山分校的消化内科研究金。
Joanne Imperial,has served as Chief Medical Officer at HepQuant LLC, a medical research company since March 2025 and as Director, Clinical Affairs since November 2024. Dr. Imperial also served as Senior Medical Director for Fortea, a medical diagnostics company, from September 2020 to October 2024; as Vice President for Blade Therapeutics, a biotechnology company, from February 2019 to September 2020; as Senior Medical Director for Conatus Pharmaceuticals, a pharmaceutical company, from February 2017 to February 2019; as Medical Director for Fibrogen, a biotech company from August 2014 to February 2017; and as Medical Director, Medical Affairs for Onyx Pharmaceuticals, a pharmaceutical company from August 2010 to August 2014. Dr. Imperial also served in various academic and professorship roles at Stanford University from April 1995 to February 2017; and as Clinical Associate Professor at University of California, San Francisco from August 2007 to February 2010. Dr Imperial holds a B.S. in Psychology from Thomas Moore University and a M.D. from New York Medical College. Dr. Imperial completed her residency in medicine and fellowship in clinical nutrition/gastroenterology at New England Deaconess Hospital and also received her fellowship in gastroenterology from University of California, San Francisco. - Joanne Imperial，自2025年起担任Capsovision，Inc.董事会成员。Imperial博士自2025年3月起担任医学研究公司HepQuant LLC的首席医疗官，并自2024年11月起担任临床事务总监。Imperial博士还曾于2020年9月至2024年10月担任医疗诊断公司Fortea的高级医疗总监；于2019年2月至2020年9月担任生物技术公司Blade Therapeutics的副总裁；于2017年2月至2019年2月担任制药公司Conatus Pharmaceuticals的高级医疗总监；于2014年8月至2017年2月担任生物技术公司Fibrogen的医疗总监；并于2010年8月至2014年8月担任制药公司Onyx Pharmaceuticals的医疗事务的医疗总监。Imperial博士还曾于1995年4月至2017年2月在斯坦福大学担任各种学术和教授职务；并于2007年8月至2010年2月担任加州大学旧金山分校临床副教授。Imperial博士拥有Thomas Moore大学的心理学学士学位和纽约医学院的医学博士学位。Imperial博士在新英格兰女执事医院完成了医学实习和临床营养/消化内科研究金，还获得了加州大学旧金山分校的消化内科研究金。
- Joanne Imperial,has served as Chief Medical Officer at HepQuant LLC, a medical research company since March 2025 and as Director, Clinical Affairs since November 2024. Dr. Imperial also served as Senior Medical Director for Fortea, a medical diagnostics company, from September 2020 to October 2024; as Vice President for Blade Therapeutics, a biotechnology company, from February 2019 to September 2020; as Senior Medical Director for Conatus Pharmaceuticals, a pharmaceutical company, from February 2017 to February 2019; as Medical Director for Fibrogen, a biotech company from August 2014 to February 2017; and as Medical Director, Medical Affairs for Onyx Pharmaceuticals, a pharmaceutical company from August 2010 to August 2014. Dr. Imperial also served in various academic and professorship roles at Stanford University from April 1995 to February 2017; and as Clinical Associate Professor at University of California, San Francisco from August 2007 to February 2010. Dr Imperial holds a B.S. in Psychology from Thomas Moore University and a M.D. from New York Medical College. Dr. Imperial completed her residency in medicine and fellowship in clinical nutrition/gastroenterology at New England Deaconess Hospital and also received her fellowship in gastroenterology from University of California, San Francisco.
- Wen Herng Henry King
-
Wen Herng Henry King，自2025年起担任Capsovision，Inc.董事会成员。自2015年以来，金先生一直担任投资公司Kashman Investment的董事长。King先生还自2019年起担任半导体IC设计公司Silergy Corp的独立董事；自2017年起担任闪存模组设计和制造公司Panram International的独立董事；自2016年起担任互连电缆公司Golden Bridge Electech的董事。King先生还曾于2015年至2024年担任集成电路设计公司Chip Hope Ltd的独立董事；于2006年至2012年担任高盛亚洲公司的董事总经理；以及在投资公司担任各种其他财务职务。金先生拥有台湾国立中央大学电气工程学士学位和芝加哥洛约拉大学工商管理硕士学位。
Wen Herng Henry King,has served as Chairman of Kashman Investment, an investment firm since 2015. Mr. King has also served as an independent director of Silergy Corp, a semiconductor IC design company since 2019; as an independent director of Panram International, a flash memory module design and manufacturing company since 2017; and as a director of Golden Bridge Electech, an interconnect cable company since 2016. Mr. King has also served as an independent director of Chip Hope Ltd, an integrated circuit design company, from 2015 to 2024; as Managing Director at Goldman Sachs Asia from 2006 to 2012; as well as various other finance roles in investment companies. Mr. King holds a B.S. in Electrical Engineering from National Central University in Taiwan and a M.B.A. from Loyola University of Chicago. - Wen Herng Henry King，自2025年起担任Capsovision，Inc.董事会成员。自2015年以来，金先生一直担任投资公司Kashman Investment的董事长。King先生还自2019年起担任半导体IC设计公司Silergy Corp的独立董事；自2017年起担任闪存模组设计和制造公司Panram International的独立董事；自2016年起担任互连电缆公司Golden Bridge Electech的董事。King先生还曾于2015年至2024年担任集成电路设计公司Chip Hope Ltd的独立董事；于2006年至2012年担任高盛亚洲公司的董事总经理；以及在投资公司担任各种其他财务职务。金先生拥有台湾国立中央大学电气工程学士学位和芝加哥洛约拉大学工商管理硕士学位。
- Wen Herng Henry King,has served as Chairman of Kashman Investment, an investment firm since 2015. Mr. King has also served as an independent director of Silergy Corp, a semiconductor IC design company since 2019; as an independent director of Panram International, a flash memory module design and manufacturing company since 2017; and as a director of Golden Bridge Electech, an interconnect cable company since 2016. Mr. King has also served as an independent director of Chip Hope Ltd, an integrated circuit design company, from 2015 to 2024; as Managing Director at Goldman Sachs Asia from 2006 to 2012; as well as various other finance roles in investment companies. Mr. King holds a B.S. in Electrical Engineering from National Central University in Taiwan and a M.B.A. from Loyola University of Chicago.
- Hui Ying Kuo
-
Hui Ying Kuo，自2024年2月起担任Capsovision，Inc.董事会成员。郭女士自2020年5月起担任公共热力解决方案提供商Asia Vital Components Co.的公司治理官；自2005年起担任电气服务公司Furukawa Electric Co.的董事；自2011年起担任宏业投资公司的监事。郭女士还曾于2008年8月至2020年5月担任Asia Vital Components Co.的审计业务总监，并于2001年至2008年担任其IPO项目经理；于1996年至2001年担任证券公司元大证券公司的承销人员；以及于1992年至1996年担任普华永道台湾公司的审计人员。郭女士拥有台湾东吴大学会计学学士学位和工商管理硕士学位。
Hui Ying Kuo,has served as a member of CapsoVision, Inc. board of directors since February 2024. Ms. Kuo has served as the Corporate Governance Officer for Asia Vital Components Co., a public thermal solutions provider since May 2020; as a Director for Furukawa Electric Co., an electrics services company since 2005; and as a Supervisor for Hongye Investment company since 2011. Ms. Kuo has also served as Director of Audit Operations for Asia Vital Components Co. from August 2008 to May 2020, and as its IPO Project Manager from 2001 to 2008; as Underwriting staff for Yuanta Securities Co, a securities company, from 1996 to 2001; and as Audit Staff for PwC Taiwan, from 1992 to 1996. Ms. Kuo holds a B.S. in Accounting and a M.B.A. from Soochow University in Taiwan. - Hui Ying Kuo，自2024年2月起担任Capsovision，Inc.董事会成员。郭女士自2020年5月起担任公共热力解决方案提供商Asia Vital Components Co.的公司治理官；自2005年起担任电气服务公司Furukawa Electric Co.的董事；自2011年起担任宏业投资公司的监事。郭女士还曾于2008年8月至2020年5月担任Asia Vital Components Co.的审计业务总监，并于2001年至2008年担任其IPO项目经理；于1996年至2001年担任证券公司元大证券公司的承销人员；以及于1992年至1996年担任普华永道台湾公司的审计人员。郭女士拥有台湾东吴大学会计学学士学位和工商管理硕士学位。
- Hui Ying Kuo,has served as a member of CapsoVision, Inc. board of directors since February 2024. Ms. Kuo has served as the Corporate Governance Officer for Asia Vital Components Co., a public thermal solutions provider since May 2020; as a Director for Furukawa Electric Co., an electrics services company since 2005; and as a Supervisor for Hongye Investment company since 2011. Ms. Kuo has also served as Director of Audit Operations for Asia Vital Components Co. from August 2008 to May 2020, and as its IPO Project Manager from 2001 to 2008; as Underwriting staff for Yuanta Securities Co, a securities company, from 1996 to 2001; and as Audit Staff for PwC Taiwan, from 1992 to 1996. Ms. Kuo holds a B.S. in Accounting and a M.B.A. from Soochow University in Taiwan.
- Michele Harari
-
Michele Harari，于2017年至2025年担任CapsoVision，Inc.董事会成员，自2016年起还担任内存技术公司SunRise Memory的董事长兼首席执行官；并于1988年至2010年担任SanDisk Corp.的创始人、董事长兼首席执行官。哈拉里女士目前拥有并维持着一个可持续发展的牧场，在那里她负责监督运营，其中包括一家人工智能农业企业。从2016年到2021年，Harari女士担任综合疗法公司Juju Life的创始人；在2016年之前，与他人共同创立了Los Gatos音乐学院。Harari女士就读于布兰代斯大学，在那里她获得了普通科学学士学位和创意写作辅修学位。
Michele Harari,served as a member of CapsoVision, Inc. board of directors from 2017 to 2025 and has also served as the Chairman and CEO of SunRise Memory since 2016, a memory technology company; and as the founder, Chairman and CEO of SanDisk Corp., from 1988 to 2010. Ms. Harari currently owns and maintains a sustainable ranch where she oversees operations that include an AI-enabled agricultural venture. From 2016 to 2021, Ms. Harari served as the founder of Juju Life, an integrative therapies company; and prior to 2016, co-founded the Los Gatos School of Music. Ms. Harari attended Brandeis University where she obtained a B.A. in General Science and a minor in Creative Writing. - Michele Harari，于2017年至2025年担任CapsoVision，Inc.董事会成员，自2016年起还担任内存技术公司SunRise Memory的董事长兼首席执行官；并于1988年至2010年担任SanDisk Corp.的创始人、董事长兼首席执行官。哈拉里女士目前拥有并维持着一个可持续发展的牧场，在那里她负责监督运营，其中包括一家人工智能农业企业。从2016年到2021年，Harari女士担任综合疗法公司Juju Life的创始人；在2016年之前，与他人共同创立了Los Gatos音乐学院。Harari女士就读于布兰代斯大学，在那里她获得了普通科学学士学位和创意写作辅修学位。
- Michele Harari,served as a member of CapsoVision, Inc. board of directors from 2017 to 2025 and has also served as the Chairman and CEO of SunRise Memory since 2016, a memory technology company; and as the founder, Chairman and CEO of SanDisk Corp., from 1988 to 2010. Ms. Harari currently owns and maintains a sustainable ranch where she oversees operations that include an AI-enabled agricultural venture. From 2016 to 2021, Ms. Harari served as the founder of Juju Life, an integrative therapies company; and prior to 2016, co-founded the Los Gatos School of Music. Ms. Harari attended Brandeis University where she obtained a B.A. in General Science and a minor in Creative Writing.
高管简历
中英对照 | 中文 | 英文- Kang HuaiWang
康怀旺是Capsovision，Inc.的联合创始人和Capsovision，Inc.董事会成员，自2024年11月起担任Capsovision，Inc.总裁兼首席执行官，在此之前于2006年10月至2024年10月担任Capsovision，Inc.总裁兼首席技术官。在加入公司之前，王先生于2003年9月至2004年11月担任技术公司ESS技术的工程副总裁；于1996年3月至2003年8月担任视频处理芯片设计公司Divio，Inc的首席执行官和联合创始人；以及于1992年3月至1995年8月担任IC设计公司C-Cube Mircrosystem的设计经理。在1992年之前，王先生在半导体行业担任过各种工程职务。王先生拥有台湾国立交通大学电机工程学学士学位，以及得克萨斯农工大学电机工程学硕士学位。
Kang HuaiWang,is a co-founder of CapsoVision, Inc. and a member of CapsoVision, Inc. board of directors, and has served as CapsoVision, Inc. President and Chief Executive Officer since November 2024, and before then CapsoVision, Inc. President and Chief Technology Officer from October 2006 to October 2024. Prior to joining the Company, Mr. Wang was Vice President of Engineering for ESS Technology, a technology company from September 2003 to November 2004; Chief Executive Officer and co-founder of Divio, Inc, a video processing chip design company, from March 1996 to August 2003; and as Design Manager for C-Cube Mircrosystem, an IC design house from March 1992 to August 1995. Prior to 1992, Mr. Wang held various engineering roles in the semiconductor industry. Mr. Wang holds a B.S. in electrical engineering from National Chiao-Tung University in Taiwan, and a M.S. in electrical engineering from Texas A&M University.- 康怀旺是Capsovision，Inc.的联合创始人和Capsovision，Inc.董事会成员，自2024年11月起担任Capsovision，Inc.总裁兼首席执行官，在此之前于2006年10月至2024年10月担任Capsovision，Inc.总裁兼首席技术官。在加入公司之前，王先生于2003年9月至2004年11月担任技术公司ESS技术的工程副总裁；于1996年3月至2003年8月担任视频处理芯片设计公司Divio，Inc的首席执行官和联合创始人；以及于1992年3月至1995年8月担任IC设计公司C-Cube Mircrosystem的设计经理。在1992年之前，王先生在半导体行业担任过各种工程职务。王先生拥有台湾国立交通大学电机工程学学士学位，以及得克萨斯农工大学电机工程学硕士学位。
- Kang HuaiWang,is a co-founder of CapsoVision, Inc. and a member of CapsoVision, Inc. board of directors, and has served as CapsoVision, Inc. President and Chief Executive Officer since November 2024, and before then CapsoVision, Inc. President and Chief Technology Officer from October 2006 to October 2024. Prior to joining the Company, Mr. Wang was Vice President of Engineering for ESS Technology, a technology company from September 2003 to November 2004; Chief Executive Officer and co-founder of Divio, Inc, a video processing chip design company, from March 1996 to August 2003; and as Design Manager for C-Cube Mircrosystem, an IC design house from March 1992 to August 1995. Prior to 1992, Mr. Wang held various engineering roles in the semiconductor industry. Mr. Wang holds a B.S. in electrical engineering from National Chiao-Tung University in Taiwan, and a M.S. in electrical engineering from Texas A&M University.
- Douglas Atkinson
Douglas Atkinson，自2016年10月起担任Capsovision，Inc.全球销售主管。在加入公司之前，Atkinson先生于2015年5月至2016年10月担任医疗器械公司Zimmer-Biomet的分销商MedTech Micro-Fixation的销售总监；于2005年1月至2015年4月担任胃肠医疗器械公司美敦力 PLC的区域销售总监。在任职于美敦力之前，Atkinson先生还曾于1995年5月至2004年12月在史赛克公司担任销售和国民账户区域总监。在史赛克，Atkinson先生因多项销售领导力和收入增长奖项而获得认可。Atkinson先生获得了杜克大学经济学和政治学学士学位。
Douglas Atkinson,joined the Company and has served as CapsoVision, Inc. Head of Global Sales since October 2016. Prior to joining the Company, Mr. Atkinson was Director of Sales for MedTech Micro-Fixation, a distributor of Zimmer-Biomet, a medical device company, from May 2015 to October 2016; as Regional Sales Director at Medtronic PLC, a gastrointestinal medical device company, from January 2005 to April 2015. Before serving at Medtronic, Mr. Atkinson also served as Regional Director of Sales and National Accounts at Stryker Corporation from May 1995 to December 2004. At Stryker, Mr. Atkinson was recognized for multiple sales leadership and revenue growth awards. Mr. Atkinson received a B.A. in economics and political science from Duke University.- Douglas Atkinson，自2016年10月起担任Capsovision，Inc.全球销售主管。在加入公司之前，Atkinson先生于2015年5月至2016年10月担任医疗器械公司Zimmer-Biomet的分销商MedTech Micro-Fixation的销售总监；于2005年1月至2015年4月担任胃肠医疗器械公司美敦力 PLC的区域销售总监。在任职于美敦力之前，Atkinson先生还曾于1995年5月至2004年12月在史赛克公司担任销售和国民账户区域总监。在史赛克，Atkinson先生因多项销售领导力和收入增长奖项而获得认可。Atkinson先生获得了杜克大学经济学和政治学学士学位。
- Douglas Atkinson,joined the Company and has served as CapsoVision, Inc. Head of Global Sales since October 2016. Prior to joining the Company, Mr. Atkinson was Director of Sales for MedTech Micro-Fixation, a distributor of Zimmer-Biomet, a medical device company, from May 2015 to October 2016; as Regional Sales Director at Medtronic PLC, a gastrointestinal medical device company, from January 2005 to April 2015. Before serving at Medtronic, Mr. Atkinson also served as Regional Director of Sales and National Accounts at Stryker Corporation from May 1995 to December 2004. At Stryker, Mr. Atkinson was recognized for multiple sales leadership and revenue growth awards. Mr. Atkinson received a B.A. in economics and political science from Duke University.
- Keri Jorgenson
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- David Garcia
David Garcia，拥有20多年的财务领导经验，最近于2020年10月至2025年10月在Matterport，Inc.担任财务规划和分析副总裁。Garcia先生还曾在View, Inc.、Intelepeer云通信、阿莱技术担任高级财务职务。
David Garcia has more than 20 years of financial leadership experience and most recently served as Vice President of Financial Planning and Analysis at Matterport, Inc. from October 2020 through October 2025. Mr. Garcia has also held senior finance roles at View, Inc., Intelepeer Cloud Communications, and Align Technology.- David Garcia，拥有20多年的财务领导经验，最近于2020年10月至2025年10月在Matterport，Inc.担任财务规划和分析副总裁。Garcia先生还曾在View, Inc.、Intelepeer云通信、阿莱技术担任高级财务职务。
- David Garcia has more than 20 years of financial leadership experience and most recently served as Vice President of Financial Planning and Analysis at Matterport, Inc. from October 2020 through October 2025. Mr. Garcia has also held senior finance roles at View, Inc., Intelepeer Cloud Communications, and Align Technology.